Gemmer Asset Management’s GSK GSK Stock Holding History

Gemmer Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-46	Closed	-$2K	–	512
2022 Q1	$2K	Hold	46	–	–	﹤0.01%	1141
2021 Q4	$3K	Sell	46 -80	-63%	-$4.16K	﹤0.01%	1117
2021 Q3	$6K	Hold	126	–	–	﹤0.01%	890
2021 Q2	$6K	Hold	126	–	–	﹤0.01%	1015
2021 Q1	$6K	Buy	126 +80	+174%	+$3.63K	﹤0.01%	972
2020 Q4	$2K	Sell	46 -107	-70%	-$4.92K	﹤0.01%	1322
2020 Q3	$7K	Hold	153	–	–	﹤0.01%	735
2020 Q2	$8K	Hold	153	–	–	﹤0.01%	673
2020 Q1	$7K	Buy	153 +46	+43%	+$2.45K	﹤0.01%	641
2019 Q4	$6K	Hold	107	–	–	﹤0.01%	873
2019 Q3	$6K	Hold	107	–	–	﹤0.01%	867
2019 Q2	$5K	Hold	107	–	–	﹤0.01%	937
2019 Q1	$6K	Hold	107	–	–	﹤0.01%	904
2018 Q4	$5K	Sell	107 -27	-20%	-$1.33K	﹤0.01%	904
2018 Q3	$7K	Buy	134 +28	+26%	+$1.42K	﹤0.01%	864
2018 Q2	$5K	Hold	106	–	–	﹤0.01%	1004
2018 Q1	$5K	Buy	+106	New	+$4.94K	﹤0.01%	980

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Gemmer Asset Management's GSK Position: Q2 2022 in Review

Gemmer Asset Management sold out of GSK (GSK) in Q2 2022, closing a stake of 46 shares — an estimated $2K sold.

Gemmer Asset Management first reported a position in GSK in Q1 2018 and held it in 17 quarters. The position peaked at $8K in Q2 2020. 900 funds tracked by Wall St. Rank hold GSK as of Q2 2022.

Gemmer Asset Management reported no remaining GSK position as of Q2 2022 after selling out during the quarter.
Gemmer Asset Management sold 46 GSK shares in Q2 2022, an estimated $2K.
Gemmer Asset Management first reported a position in GSK in Q1 2018 and held it in 17 quarters.
Gemmer Asset Management's GSK position peaked at $8K in Q2 2020.
900 funds tracked by Wall St. Rank held GSK as of Q2 2022.

Based on Gemmer Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.